Stefan Russmann

Summary

Affiliation: University Hospital
Country: Switzerland

Publications

  1. ncbi Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation
    Florian Bihl
    Department of Gastroenterology and Hepatology, University Hospital of Geneva, Switzerland
    BMC Gastroenterol 10:71. 2010
  2. ncbi Current concepts of mechanisms in drug-induced hepatotoxicity
    Stefan Russmann
    Division of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland
    Curr Med Chem 16:3041-53. 2009
  3. ncbi [Adverse reactions and risks associated with non compliance]
    Stefan Russmann
    Klinik für Klinische Pharmakologie und Toxikologie, Universitatsspital Zurich
    Ther Umsch 67:303-7. 2010
  4. ncbi Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatients
    Olesya I Zorina
    Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland
    Pharmacoepidemiol Drug Saf 21:872-80. 2012
  5. ncbi Comparative evaluation of three clinical decision support systems: prospective screening for medication errors in 100 medical inpatients
    Daniela Fritz
    Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
    Eur J Clin Pharmacol 68:1209-19. 2012
  6. ncbi Evaluation of medication safety in the discharge medication of 509 surgical inpatients using electronic prescription support software and an extended operational interaction classification
    Thomas Frölich
    Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland
    Eur J Clin Pharmacol 67:1273-82. 2011
  7. ncbi Medication wrong route administration: a poisons center-based study
    Alexandra Bloch-Teitelbaum
    Associated Institute of the University of Zurich, Swiss Toxicological Information Centre, Zurich, Switzerland
    Expert Opin Drug Saf 12:145-52. 2013
  8. ncbi Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System)
    Markus Guzek
    Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland
    Pharmacoepidemiol Drug Saf 20:930-8. 2011
  9. ncbi Pharmacogenetics of drug-induced liver injury
    Stefan Russmann
    Division of Clinical Pharmacology and Toxicology, University Hospital Zurich, Switzerland
    Hepatology 52:748-61. 2010
  10. ncbi Phynx: an open source software solution supporting data management and web-based patient-level data review for drug safety studies in the general practice research database and other health care databases
    Marco Egbring
    Division of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091Zurich, Switzerland
    Pharmacoepidemiol Drug Saf 19:38-44. 2010

Collaborators

  • Gerd A Kullak-Ublick
  • Martin Huber
  • Marco Egbring
  • Christine Rauber-Lüthy
  • Ignazio Grattagliano
  • Olesya I Zorina
  • Markus Guzek
  • Alexandra Bloch-Teitelbaum
  • Alessandro Ceschi
  • Daniela Fritz
  • Roman R Gonzenbach
  • Michael Weller
  • Alexander Semmler
  • Thomas Frölich
  • Florian Bihl
  • Hugo Kupferschmidt
  • Saskia Lüde
  • Patrick Haueis
  • Ivanka Curkovic
  • Isabelle Marti
  • Olesya Zorina
  • Andrea O Fontana
  • Andreas Vollenweider
  • Martine Michel
  • Antoine Hadengue
  • Loredana Pizzi-Bosman
  • Damiano Castelli
  • Pietro Majno
  • Emiliano Giostra
  • Gilles Mentha
  • Loriana Di Giammarino
  • Vanina Gurtner
  • Andreas Cerny

Detail Information

Publications10

  1. ncbi Hyperimmune anti-HBs plasma as alternative to commercial immunoglobulins for prevention of HBV recurrence after liver transplantation
    Florian Bihl
    Department of Gastroenterology and Hepatology, University Hospital of Geneva, Switzerland
    BMC Gastroenterol 10:71. 2010
    ..However, associated treatment costs for HBIG are exceedingly high...
  2. ncbi Current concepts of mechanisms in drug-induced hepatotoxicity
    Stefan Russmann
    Division of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland
    Curr Med Chem 16:3041-53. 2009
    ..However, the complexity of interactions between genetic and environmental risk factors is considerable, and DILI therefore currently remains unpredictable for most hepatotoxins...
  3. ncbi [Adverse reactions and risks associated with non compliance]
    Stefan Russmann
    Klinik für Klinische Pharmakologie und Toxikologie, Universitatsspital Zurich
    Ther Umsch 67:303-7. 2010
    ..Computerized physician order entry and clinical decision support systems may have an additional important role for the prevention of non compliance in the future...
  4. ncbi Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatients
    Olesya I Zorina
    Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland
    Pharmacoepidemiol Drug Saf 21:872-80. 2012
    ..The comparative evaluation of clinical decision support software (CDSS) programs regarding their sensitivity and positive predictive value for the identification of clinically relevant drug interactions...
  5. ncbi Comparative evaluation of three clinical decision support systems: prospective screening for medication errors in 100 medical inpatients
    Daniela Fritz
    Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Ramistrasse 100, 8091 Zurich, Switzerland
    Eur J Clin Pharmacol 68:1209-19. 2012
    ..Clinical decision support systems (CDSS) are promoted as powerful screening tools to improve pharmacotherapy. The aim of our study was to evaluate the potential contribution of CDSS to patient management in clinical practice...
  6. ncbi Evaluation of medication safety in the discharge medication of 509 surgical inpatients using electronic prescription support software and an extended operational interaction classification
    Thomas Frölich
    Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Ramistrasse 100, 8091, Zurich, Switzerland
    Eur J Clin Pharmacol 67:1273-82. 2011
    ....
  7. ncbi Medication wrong route administration: a poisons center-based study
    Alexandra Bloch-Teitelbaum
    Associated Institute of the University of Zurich, Swiss Toxicological Information Centre, Zurich, Switzerland
    Expert Opin Drug Saf 12:145-52. 2013
    ..To describe clinical effects, circumstances of occurrence, management and outcomes of cases of inadvertent administration of medications by an incorrect parenteral route...
  8. ncbi Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System)
    Markus Guzek
    Department of Clinical Pharmacology and Toxicology, University Hospital Zurich, Zurich, Switzerland
    Pharmacoepidemiol Drug Saf 20:930-8. 2011
    ..Reclassification of interactions with a focus on clinical management aimed to support the development of CDSS with higher efficacy to reduce overalerting and improve medication safety in clinical practice...
  9. ncbi Pharmacogenetics of drug-induced liver injury
    Stefan Russmann
    Division of Clinical Pharmacology and Toxicology, University Hospital Zurich, Switzerland
    Hepatology 52:748-61. 2010
    ..However, DILI is a rare complex disease, and pharmacogenetic studies have so far not been able to identify interactions of several risk factors defining a high population-attributable risk and clinically relevant absolute risk for DILI...
  10. ncbi Phynx: an open source software solution supporting data management and web-based patient-level data review for drug safety studies in the general practice research database and other health care databases
    Marco Egbring
    Division of Clinical Pharmacology and Toxicology, University Hospital Zurich, 8091Zurich, Switzerland
    Pharmacoepidemiol Drug Saf 19:38-44. 2010
    ..To develop a software solution that supports management and clinical review of patient data from electronic medical records databases or claims databases for pharmacoepidemiological drug safety studies...